Identification and Characterization of a Mammalian Enzyme Catalyzing the Asymmetric Oxidative Cleavage of Provitamin A*

Cornelia KieferDagger §, Susanne HesselDagger §, Johanna M. LampertDagger , Klaus VogtDagger , Markus O. Lederer, Dietmar E. Breithaupt, and Johannes von LintigDagger ||

From the Dagger  University of Freiburg, Instiute of Biology I, Animal Physiology and Neurobiology, Hauptstrasse 1, D-79104 Freiburg, Germany and the  University of Hohenheim, Institut für Lebensmittelchemie, Garbenstrasse 28, D-70599 Stuttgart, Germany

Received for publication, December 20, 2000, and in revised form, January 26, 2001




    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

In vertebrates, symmetric versus asymmetric cleavage of beta -carotene in the biosynthesis of vitamin A and its derivatives has been controversially discussed. Recently we have been able to identify a cDNA encoding a metazoan beta ,beta -carotene-15,15'-dioxygenase from the fruit fly Drosophila melanogaster. This enzyme catalyzes the key step in vitamin A biosynthesis, symmetrically cleaving beta -carotene to give two molecules of retinal. Mutations in the corresponding gene are known to lead to a blind, vitamin A-deficient phenotype. Orthologs of this enzyme have very recently been found also in vertebrates and molecularly characterized. Here we report the identification of a cDNA from mouse encoding a second type of carotene dioxygenase catalyzing exclusively the asymmetric oxidative cleavage of beta -carotene at the 9',10' double bond of beta -carotene and resulting in the formation of beta -apo-10'-carotenal and beta -ionone, a substance known as a floral scent from roses, for example. Besides beta -carotene, lycopene is also oxidatively cleaved by the enzyme. The deduced amino acid sequence shares significant sequence identity with the beta ,beta -carotene-15,15'-dioxygenases, and the two enzyme types have several conserved motifs. To establish its occurrence in different vertebrates, we then attempted and succeeded in cloning cDNAs encoding this new type of carotene dioxygenase from human and zebrafish as well. As regards their possible role, the apocarotenals formed by this enzyme may be the precursors for the biosynthesis of retinoic acid or exert unknown physiological effects. Thus, in contrast to Drosophila, in vertebrates both symmetric and asymmetric cleavage pathways exist for carotenes, revealing a greater complexity of carotene metabolism.




    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Vitamin A and its analogs have a variety of physiological functions. Retinal or related compounds such as 3-hydroxyretinal serve as the chromophores of various visual pigments (rhodopsins) throughout the animal kingdom (1, 2). In vertebrates, the vitamin A derivative retinoic acid (RA)1 additionally exerts effects in development and cell differentiation by binding to specific nuclear receptors involved in the regulation of gene transcription (3-5). The key step in the formation of vitamin A is the oxidative cleavage of beta -carotene by enzymes encoded in the genome of the animal. The properties of these enzymes have been a subject of controversy because both symmetric and asymmetric cleavage of beta -carotene was reported in crude extracts (6-8) (Fig. 1). Thanks to its sequence similarity to a plant carotenoid-cleaving enzyme, VP14 (9-cis neoxanthin cleavage enzyme from Zea mais) (9), we have been able to clone from a metazoan (the fruit fly Drosophila melanogaster) a cDNA encoding a beta ,beta -carotene-15,15'-dioxygenase (beta -diox) catalyzing exclusively the symmetric cleavage of beta -carotene to give two molecules of retinal (10). Orthologs of this enzyme have since been cloned and characterized from the chicken and the mouse by others (11, 12). The enzymes belong to a widespread and diverse class of polyene chain dioxygenases previously described in bacteria and plants (10, 13). Besides the beta -diox, in vertebrates another putative polyene chain dioxygenase, RPE65, is found (14, 15). A function in retinoid metabolism for this protein was proposed by mutant analysis, but its biochemical function is still unknown (16).



View larger version (14K):
[in this window]
[in a new window]
 
Fig. 1.   Schematic overview of mammalian beta -carotene/retinoid metabolism. Solid arrows, vitamin A formation by the symmetric cleavage pathway. The retinal formed can be further metabolized to give retinol and retinylesters (storage) or can be oxidized to give retinoic acid. Broken arrows, beta -apo-carotenal (8', 10', 12') formation by the asymmetric cleavage of beta -carotene. For retinoic acid formation the beta -apocarotenals have to be shortened by a mechanism similar to beta -oxidation of fatty acids (for further details see the Introduction).

In contrast, in Drosophila only one representative of this class of enzymes is found, and mutations in the corresponding gene (ninaB) cause a blind, vitamin A-deficient phenotype (17), demonstrating that vitamin A is formed exclusively by the symmetric cleavage of the provitamin. Besides this blindness, no other defect becomes manifest; so here vitamin A functions are restricted to the visual system. In vertebrates, vitamin A formation and metabolism are probably more complex, considering the multiple vitamin A effects in development and cell differentiation exerted by its metabolite, RA. This inference is strengthened by the fact that besides the formation of RA from retinal, as the initial product of symmetric beta -carotene cleavage, direct formation of RA from beta -carotene has been described in vertebrates (18). In these investigations retinal was not found to be an intermediate in RA formation, indicating that an alternative pathway for RA formation is present in vertebrates. Biochemical evidence for this alternative pathway in RA formation comes from the observation that, besides symmetric cleavage of beta -carotene, asymmetric cleavage occurs (7, 19, 20). This asymmetric cleavage leads to the formation of two molecules of beta -apocarotenal with different chain lengths. For RA formation, the beta -apocarotenal with the longer chain length must be shortened, yielding one molecule of RA. For this, a mechanism similar to the beta -oxidation of fatty acids has been proposed (21). Furthermore, in vertebrates several physiological effects are caused by beta -carotene (22). beta -carotene itself or metabolites derived from it by alternative oxidative cleavage reactions are most likely responsible. Therefore, vertebrate beta -carotene metabolism and especially RA formation could well be more complex and not just a matter of producing retinal and converting it to retinoic acid.

Taking the mouse as a model for vertebrate beta -carotene metabolism, we searched EST libraries for additional putative polyene chain dioxygenases. Here we report on the cloning and biochemical characterization of a carotene dioxygenase catalyzing the asymmetric cleavage of beta -carotene. We were able to identify the cleavage products as beta -apo-10'-carotenal (C27) and beta -ionone (C13) from beta -carotene (C40). In addition, this new type of metazoan polyene chain dioxygenase catalyzes the oxidative cleavage of lycopene, resulting in the formation of apolycopenals. The existence of two different types of carotene dioxygenases in vertebrates was verified by cloning the corresponding cDNAs from man and the zebrafish. Thus, asymmetric cleavage of beta -carotene exists in vertebrates and may provide a precursor for RA formation and/or may exert until now unknown physiological functions.


    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Sequence Comparison and Phylogenetic Tree Analysis-- Vector NTI suite 6.0 (InforMax Inc., Oxford, UK) was used.

Chemicals-- The following chemicals were used: beta -ionone (Roth, Karlsruhe, Germany), beta -apo-12'-carotenal (BASF, Ludwigshafen, Germany), and beta -apo-8'-carotenal (Sigma).

Preparation of Total RNA from Different Tissues of Mice-- For the experiments 7-week-old BALB/c mice (male and female) were sacrified, and different tissues (colon, small intestine, stomach, spleen, brain, liver, heart, kidney, lung, and testis) were dissected by hand and frozen immediately in liquid nitrogen. 50-100 mg of each tissue was homogenized with a pestle in a mortar with liquid nitrogen, and total RNA was isolated using the RNeasy kit (Qiagen, Hilden, Germany). The concentrations of the isolated total RNA were determined spectrophotometrically.

Cloning of cDNAs Encoding beta -Diox-homologous Proteins from the Mouse-- For cloning of full-length cDNAs encoding putative mouse beta -carotene dioxygenases, RACE-PCRs were performed using a 5'/3' RACE kit (Roche Molecular Biochemicals). Reverse transcription was carried out using 500 ng of total RNA isolated from liver, an oligo(dT) anchor primer, and Superscript reverse transcriptase (Life Technologies, Inc.). For PCR the Expand PCR system (Roche Molecular Biochemicals), an anchor primer, and a specific up-primer, 5'-ATGGAGATAATATTTGGCCAG-3' for beta -diox and 5'-ATGTTGGGACCGAAGCAAAGC-3' for beta -diox-II, were used. The PCR products were ligated into the vector pBAD-TOPO (Invitrogen), resulting in the plasmids pDiox and pDiox-II.

Tissue-specific Expression of beta -Carotene Dioxygenases in the Mouse-- With total RNA (100 ng) isolated from different tissues, RT-PCR was performed as has been described (23). The following sets of primers were used: beta -diox, up, 5'-ATGGAGATAATATTTGGCCAG-3', and down, 5'-AACTCAGACACCACGATTC-3'; beta -diox-II, up, 5'-ATGTTGGGACCGAAGCAAAGC-3', and down, 5'-TGTGCTCATGTAGTAATCACC-3'. As a control for the intactness of the individual RNA samples, the mRNA of beta -actin was analyzed using the following primers: up, 5'-CCAACCGTGAAAAGATGACCC-3'; down, 5'-CAGCAATGCCTGGGTACATGG-3'.

Determination of the Enzymatic Activity in Vitro-- For heterologous expression of the beta -diox-II the plasmid pDiox-II was transformed in the Escherichia coli strain XL1-blue (Stratagene Inc., La Jolla, CA). The bacterial culture was grown at 28 °C until it reached an A600 of 1.0. Then, L-(+)-arabinose was added to a final concentration of 0.8% (w/v), and the bacteria were cultivated for an additional 3 h. After being harvesting, the bacteria were broken with a French press in a buffer containing 50 mM Tricine/KOH (pH 7.6), 100 mM NaCl, and 1 mM dithiothreitol. The crude extract was centrifuged at 20,000 × g for 20 min. The supernatant was dialyzed against the same buffer for 1 h at 4 °C. Enzymatic activity was determined in crude extracts (100 µg of total protein) as described (24) by adding beta -carotene in micelles of Tween 40 with a final concentration of 300 µM beta -carotene and 0.2% Tween 40 in the assay. Then the lipophilic compounds were extracted and subjected to HPLC analysis as described (10).

HPLC Analysis of beta -Carotene- and Lycopene-accumulating E. coli Strains Expressing the Two Different beta -Carotene Dioxygenases from the Mouse-- The plasmids pDiox and pDiox-II were transformed into the appropriate E. coli strain. Growing conditions and analysis of the carotenes and their cleavage products were as previously described (10).

Mass Spectroscopy of the Cleavage Products by LC-MS and GC-MS-- The E. coli strains were cultivated overnight, and the bacteria were harvested by centrifugation. For solid phase extraction an SPME syringe (100 µm PDMS, Supelco, Deisenhofen, Germany) was incubated in the supernatant for 15 min. Then the compounds absorbed to the solid phase were subjected directly to GC-MS (GC: Hewlett-Packard 6890; MS: Hewlett-Packard 5973 (70 eV), Waldbronn, Germany) with a temperature program starting at 100 °C and increasing 6 °C/min to 300 °C. A DB-1 column (30 m × 0.25 mm × 0.25 µm film thickness, J & W, Folsom, Canada) was used with helium as the carrier gas. For LC-MS analysis the bacterial pellet was extracted in the presence of hydroxylamine as previously described (10). LC-MS was run on an HP1100 HPLC module system (Hewlett-Packard), coupled to a Micromass (Manchester, UK) VG platform II quadrupole mass spectrometer equipped with an APcI (atmospheric pressure chemical ionization) interface. UV absorbance was monitored with a diode array detector. MS parameters (APcI+ mode) were as follows: source temperature, 120 °C; APcI probe temperature, 350 °C; corona, 3.2 kV; high voltage lens, 0.5 kV; cone voltage, 30 V. The system was operated in full scan mode (m/z 250-1000). For data acquisition and processing, MassLynx 3.2 software was used. For peak separation, a Nucleosil RP-C18 column (5 µm; 250 × 4.6 mm) from Bischoff (Leonberg, Germany) was used and kept at 25 °C. The mobile phases consisted of a mixture of acetonitrile and methanol at 85:15 (v/v) (A) and isopropanol (B); the gradient (% A (min)) was as follows: 100 (8), 70 (10), 70 (25), 100 (28), 100 (32). The flow rate was 1 ml/min, and the injection volume was 20 µl.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Cloning of a cDNA Encoding a New Type of Carotene Dioxygenase-- For the cloning of the cDNA encoding the new type of carotene dioxygenase, we searched mouse EST data bases and found an EST fragment (AW044715) with significant peptide sequence similarity to the RPE65 and the recently characterized beta -dioxes from Drosophila, the chicken, and the mouse (10-12). However, it was not identical with the mouse RPE65 and beta -diox and thus represented a new heretofore unknown representative of this class of polyene chain dioxygenases. To obtain a full-length cDNA, we designed upstream primers deduced from the EST fragment. Then we performed RACE-PCR on a total RNA preparation derived from the liver of a 7-week-old BALB/c male mouse. The PCR product was cloned into the vector pBAD-TOPO, and sequence analyses were carried out. The cDNA encoded a protein of 532 amino acids. Sequence comparison revealed that the deduced amino acid sequence shared 39% sequence identity with the mouse beta ,beta -carotene-15,15'-dioxygenase (Fig. 2). Several highly conserved stretches of amino acids and six conserved histidines probably involved in binding the cofactor Fe2+ were found (10), indicating that the encoded proteins belong to the same class of enzymes. Thus, in the mouse, besides the beta -diox and RPE65, a third type of polyene chain dioxygenase (beta -diox-II) exists.



View larger version (52K):
[in this window]
[in a new window]
 
Fig. 2.   Comparison of the deduced amino acid sequences of the two types of carotene dioxygenases from mouse. A linear alignment of the deduced amino acid sequences of the mouse beta -diox and beta -diox-II from the mouse is shown. Identity is indicated in black, and conserved amino acids, according to the PAM250 matrix, are indicated in gray. Six conserved histidine residues probably involved in binding the cofactor Fe2+ are marked by asterisks.

The New Type of Carotene Dioxygenase Catalyzes the Asymmetric Cleavage of beta -Carotene, Resulting in the Formation of beta -Apo-10'-carotenal and beta -Ionone-- For functional characterization of beta -diox-II, we expressed it as a recombinant protein in E. coli and performed an in vitro test for enzymatic activity under the conditions described for beta -diox (24). HPLC analysis revealed that no retinoids were formed from beta -carotene. However, a compound with a retention time of 4.6 min was detected (Fig. 3A). In the presence of hydroxylamine during extraction, the retention time of this compound shifted from 4.6 to 16 min, indicating that the compound has an aldehyde group from which the corresponding oxime can be formed (Fig. 3B). The increase of the putative beta -carotene cleavage product catalyzed by the new type of beta -carotene dioxygenase was linear up to 2 h of incubation time. The UV-visible absorbance spectra of the compounds resembled those of beta -apocarotenals and beta -apocarotenaloximes, respectively (Fig. 3C). However, they were not identical with beta -apo-8'-carotenal/oxime and beta -apo-12'-carotenal/oxime, as judged by comparing the spectra of reference substances in stock in our laboratory. The spectra resembled the spectra of beta -apo-10'-carotenal (424 nm) and beta -apo-10'-carotenaloxime (435 nm) as found in the literature (25). A definite identification of the compounds would require further investigations. However, the turnover rates and, therefore, the amounts of cleavage product formed were quite low in vitro, as already observed for the beta -dioxes (10-12). To obtain large amounts of this substance for further chemical analysis, we decided to take advantage of an E. coli test system already successfully used to characterize the beta -diox from Drosophila (10). This test system offered the advantage of combining beta -carotene biosynthesis and further metabolism by carotene dioxygenases in one organism. In the case of retinoid formation catalyzed by beta -diox, beta -carotene cleavage became visible by a color shift of the bacteria. As a control we used the beta -diox from the mouse. Whereas the E. coli strain expressing the beta -diox from the mouse became white, in the E. coli strain expressing the beta -diox-II no such pronounced color shift occurred (Fig. 4). However, the beta -carotene content of the E. coli strain expressing the beta -diox-II was significantly reduced compared with a control strain (22.8 pmol/mg of dry weight versus 60.9 pmol/mg of dry weight of the E. coli control strain). To identify the putative cleavage products, we extracted and subjected them to HPLC analyses as has been described (10). Besides beta -carotene, six peaks were detected, which were assigned to two classes of compounds by their UV-visible absorbance spectra (Fig. 5). The first class (peaks 2, 5, and 6) showed an absorbance maximum at 424 nm, identical with the putative beta -apo-10'-carotenaloxime already found in the in vitro tests (Figs. 3C and 5, B and C). The second class of compounds (peaks 1, 3, and 4) had an absorbance maximum at 386 nm and a UV-visible spectrum resembling that of beta -apo-10'-carotenol (25) (Fig. 5, B and D). The occurrence of compounds with the same absorbance spectra but different retention times could be due to the stereoisomeric composition of the products formed and/or, in the case of the aldehydes, due to the syn or anti configuration of the oximes formed. Depending on the induction time, first the putative beta -apo-10'-carotenal and then the putative beta -apo-10'-carotenol became detectable, indicating that the aldehyde is converted to the corresponding alcohol in E. coli (data not shown). The conversion of retinal to the corresponding alcohol retinol in E. coli was already found by expressing the beta -diox from Drosophila or from the mouse as shown here (Fig. 5A). To positively identify the putative beta -apo-10'-carotenal formed, we converted it to the corresponding beta -apo-10'-carotenaloxime and subjected it to LC-MS analyses. Because the system was operated in the APcI+ mode, quasimolecular ions generally appeared as [M + H]+ signals. beta -apo-10'-carotenaloxime was identified by its quasimolecular ion at m/z 392 [M + H]+, which is the base peak of the spectrum. The even-numbered [M + H]+ mass signal clearly proved the presence of a nitrogen in the compound and thus established the transformation of the aldehyde group into the corresponding oxime. Fragmentation of the polyene chain, yielding characteristic daughter ions, was not observed. Additionally, the characteristic UV-visible spectrum, showing maxima at 405 (shoulder), 424, and 446 nm, is in accordance with the chromophoric system of beta -apo-10'-carotenaloxime and consistent with spectroscopic data reported previously (25).



View larger version (12K):
[in this window]
[in a new window]
 
Fig. 3.   Analyses of the products formed in in vitro tests for enzymatic activity conducted with beta -diox-II. Crude extracts from E. coli expressing beta -diox-II were incubated in the presence of beta -carotene for 2 h. Then the compounds formed were extracted, and HPLC analyses were carried out. A, formaldehyde/chloroform extract; B, hydroxylamine/methanol extract. After extraction in the presence of formaldehyde/chloroform, a compound with a retention time of 4.6 min was detected, whereas in the presence of hydroxylamine/chloroform its retention time shifted to 16 min. C, UV-visible spectrum of peak 1. D, UV-visible spectrum of peak 2.



View larger version (51K):
[in this window]
[in a new window]
 
Fig. 4.   Colors of beta -carotene- and lycopene-synthesizing and -accumulating E. coli strains after expressing either the beta -diox or beta -diox-II. A, beta -carotene-accumulating E. coli control strain; B, beta -carotene-accumulating strain expressing beta -diox from the mouse; C, beta -carotene-accumulating strain expressing beta -diox-II; D, lycopene-accumulating strain expressing beta -diox-II; E, lycopene-accumulating control strain.



View larger version (17K):
[in this window]
[in a new window]
 
Fig. 5.   HPLC analyses of the beta -carotene cleavage products formed in beta -carotene-producing and -accumulating E. coli expressing beta -diox or beta -diox-II. Bacteria pellets were extracted with the hydroxylamine/methanol method as has been described (10). A, HPLC profile at 360 nm of an extract derived from an E. coli strain expressing beta -diox (upper trace) from the mouse compared with a control extract (lower trace). The composition of the retinoids found is indicated in the figure. B, HPLC profile at 400 nm of an extract derived from an E. coli strain expressing beta -diox-II (upper trace) from the mouse compared with a control extract (lower trace). Six substances were detected and assigned to two different classes of compounds, beta -apo-10'-carotenaloxime (C) (peaks 2, 5, and 6) and beta -apo-10'-carotenol (D) (peaks 1, 3, and 4) based on their UV-visible spectra and LC-MS analysis.

Thus, from beta -carotene beta -apo-10'-carotenal is formed. However, the second compound that should result from the oxidative cleavage of beta -carotene at the 9',10' double bond of beta -carotene, beta -ionone, was not detectable by HPLC. This could be explained by its volatility and/or its partitioning to the medium. Therefore, we analyzed the bacterial growth medium after solid phase extraction of lipophilic compounds by GC-MS. In the medium of the E. coli strain expressing beta -diox-II, significant amounts of beta -ionone (identical in its retention time and mass spectra to a beta -ionone standard) was detected, and these were not found in the medium of the E. coli control strain. Taken together, the analyses demonstrated that beta -diox-II catalyzes the asymmetric cleavage of beta -carotene at the 9',10' carbon double bond, resulting in the formation of beta -apo-10'-carotenal and beta -ionone. Therefore, we have termed this enzyme beta ,beta -carotene-9',10'-dioxygenase.

To test whether the enzyme catalyzes the oxidative cleavage of carotenes different from beta -carotene, we transformed it into an E. coli strain able to synthesize and accumulate lycopene (Fig. 4). The experiment was performed as described above. In this strain significant amounts of putative apolycopenals became detectable. This was shown by converting the aldehydes to the corresponding oximes (data not shown). Therefore, the new type of carotene dioxygenase catalyzes the oxidative cleavage of lycopene in the E. coli test system as well, resulting in the formation of apolycopenals tentatively identified by their UV-visible spectra.

Cloning of cDNAs Encoding the New Type of Carotene Dioxygenase from Man and the Zebrafish-- To verify the existence of the second type of dioxygenase, beta -diox-II, in other metazoan organisms, we searched for EST fragments with sequence identity in the data base. We found EST fragments from man and the zebrafish. Then we cloned and sequenced the corresponding full-length cDNAs. The cDNA cloned from total RNA derived from human liver encoded a protein of 556 amino acids, whereas the cDNA isolated from the zebrafish encoded a protein of 549 amino acids. The deduced amino acid sequences shared 72 and 49% sequence identity, respectively, to the mouse beta -diox-II. We performed a phylogenetic tree calculation based on a sequence distance method and utilized a neighbor-joining algorithm (26) with the deduced amino acid sequences of the metazoan polyene chain dioxygenases and the plant VP14. As shown in Fig. 6, in vertebrates three groups of polyene chain dioxygenases are found: the two different beta -carotene dioxygenases and RPE65. The sequence analysis revealed that the three vertebrate polyene chain dioxygenases most likely emerged from a common ancestor. In contrast, in Drosophila and Caenorhabditis elegans, only one type of dioxygenase was found in the entire genome. As judged by the E. coli test system, the C. elegans dioxygenase catalyzes the symmetric cleavage of beta -carotene to form retinal. Therefore, the occurrence of additional genes encoding this class of enzymes, the beta -diox-II and the RPE65, is apparently related to vertebrate carotene/retinoid metabolism.



View larger version (10K):
[in this window]
[in a new window]
 
Fig. 6.   Phylogenetic tree calculation of the metazoan polyene chain dioxygenases and the plant VP14. The phylogenetic tree calculation was based on a sequence distance method and utilized the neighbor-joining algorithm (26) with the deduced amino acid sequences of metazoan polyene chain dioxygenases and the plant VP14 (9). The two different types of vertebrate carotene dioxygenases are indicated by the numbers 1 (beta -diox) and 2 (beta -diox-II) after the name of the organism. Besides the sequences reported here, the following sequences were used: human-1 (AAG15380), mouse-1 (12), RPE65 human (XP001366), RPE65 bovine (A47143), Drosophila (10), VP14 (AAB62181).

Tissue-specific Expression of the New Type of Carotene Dioxygenase-- We analyzed total RNA from several tissues of 7-week-old BALB/c mice (male and female) and estimated the steady-state mRNA levels of the two types of carotene dioxygenases by RT-PCR analyses. RT-PCR products of both types of carotene dioxygenase mRNAs became detectable in small intestine, liver, kidney, and testis, whereas low abundance steady-state mRNA of the new type of carotene dioxygenase was additionally present in spleen, brain, lung, and heart (Fig. 7). The intactness of the RNA preparations was verified by analyzing the beta -actin mRNA. By omitting the reverse transcriptase in the assays, it was shown that the RT-PCR products derived from mRNA and not from DNA contaminations. By using a multiple tissue mRNA blot (CLONTECH), analyzed with a riboprobe of the human cDNA, we were able to find a 2.2-kilobase pair message in heart and liver for the new type of carotene dioxygenase, whereas a transcript of 2.4 kilobase pairs for the beta -diox was found mainly in kidney (data not shown).



View larger version (58K):
[in this window]
[in a new window]
 
Fig. 7.   Estimation of the steady-state mRNA levels of the two types of carotene dioxygenases in different tissues of mouse. Analyses of beta -diox, beta -diox-II, and beta -actin mRNA levels in various tissues of mouse by RT-PCR analyses. For analyses the reaction products were loaded on an agarose (1.2%) gel containing 1 × 90 mM Tris, 90 mM boric acid, 2 mM EDTA, pH 8, and 0.2 µg·ml-1 ethidium bromide. The gel was stained with ethidium bromide, and the photographs are shown. For each sample the analysis was carried out in the presence (+) and absence (-) of reverse transcriptase to demonstrate that PCR products derived from mRNA.



    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Here, we report on the cloning, characterization, and tissue-specific expression of a new type of carotene dioxygenase from mouse catalyzing the asymmetric cleavage of beta -carotene. By expressing the enzyme in a beta -carotene-synthesizing E. coli strain, beta -apocarotenal formation at the expense of beta -carotene was shown. The cleavage products formed were identified by their absorbance spectra, by the conversion of the aldehyde to the corresponding oxime, and by LC-MS or GC-MS as being beta -apo-10'-carotenal and beta -ionone. In vitro, the enzyme catalyzed the same reaction as in the E. coli test system. Thus, the characterized enzyme catalyzed the oxidative cleavage at the 9'-10' double bond in the polyene backbone of its substrate, beta -carotene.

Besides the overall sequence identity to the beta -diox previously described (10-12), there is a distinct conserved pattern of histidine residues, which has been proposed to be involved in the binding of the cofactor Fe2+ (12). Thus, including RPE65, three different representatives of the polyene chain dioxygenase family are found in vertebrates. Although the biochemical function of the RPE65 protein remains to be elucidated, we show that besides symmetrical cleavage of beta -carotene, asymmetric cleavage also occurs, positively resolving the controversial debate on the significance of this reaction. The analysis of the tissue-specific expression showed that mRNAs for both enzymes are found together in several tissues, e.g. small intestine and liver. These findings verify biochemical results on the molecular level that both symmetric and asymmetric cleavage of beta -carotene can be found in the same tissue. The expression patterns in the mouse and man were not consistent. This could be either because of interspecies differences in carotene metabolism or reflect differences in the age and nutritional status of the individuals investigated, thus possibly presenting an additional factor to explain the conflicting results obtained in several investigations. In earlier studies conducted with tissue homogenates, a variety of beta -apocarotenals of different chain length resulting from asymmetric beta -carotene cleavage were found. Therefore, the term random cleavage was used for this reaction by several authors. Here we show that the characterized enzyme does not catalyze such side reactions; instead it is specific for the 9',10' double bond. The formation of beta -apocarotenals different from beta -apo-10'-carotenal found in vitro may be caused by further metabolism of the primary cleavage product or by additional, yet unknown, carotene dioxygenases. However, the in vitro activity of the metazoan polyene chain dioxygenases is difficult to obtain, and beta -apocarotenal formation from beta -carotene by nonenzymatic degradation has been reported in an aqueous environment (27).

After the molecular identification of a cDNA encoding this new type of carotene dioxygenase, the question arose as to the physiological relevance in vertebrate carotene metabolism. Sharma et al. (28) showed in rats and chickens that beta -apocarotenals can be bioactive precursors for RA formation. After absorption of these compounds, the corresponding acid is first formed and then shortened to yield retinoic acid. The same study also showed that only small proportions of beta -apocarotenals are attacked by the beta -diox to give retinal. This possibility could be of importance considering the co-expression of both dioxygenases in several tissues shown here. Napoli and Race (18) showed that several tissues are able to synthesize RA and that retinal, the primary product of the symmetric cleavage of beta -carotene, was not detected as an intermediate. By analyzing RA formation from beta -apocarotenals, a mechanism similar to beta -oxidation of fatty acids was proposed by Wang et al. (21). In their study, RA formation from beta -apocarotenals was ensured by giving citral, a potent inhibitor of retinalaldehyde dehydrogenases that catalyze the oxidation of retinal to RA. Therefore, the asymmetric cleavage reaction most likely represents the first step in an alternative pathway in the formation of RA and may contribute to RA homeostasis of the body, certain tissues, or cells. The second product resulting from asymmetric cleavage, beta -ionone, is known as a scent compound in plants. This short chain compound is volatile, and a putative physiological role in animals remains to be investigated.

In Drosophila vitamin A is exclusively formed by the symmetric cleavage reaction (17). In vertebrates the two different carotene dioxygenases and the RPE65 protein are found. Sequence comparison indicated that the vertebrate dioxygenases arose from a common ancestor. In contrast to Drosophila, in vertebrates RA plays an important role in development and cell differentiation. Thus, the existence of different beta -carotene dioxygenases could be related to the emergence of RA effects. By in situ hybridization in zebrafish embryos, high steady-state mRNA levels of the zebrafish homologue of the beta -diox were found before gastrulation. The zebrafish homologue to the beta -carotene-9',10'-dioxygenase could only be detected after organogenesis.2 The finding of high steady-state mRNA levels of the beta -diox at early times in development has been reported recently for the mouse (12). This indicates that retinoid formation from beta -carotene catalyzed by the symmetric oxidative cleavage reaction may contribute to the retinoid homeostasis of the embryo. Therefore, besides maternal, preformed vitamin A, de novo biosynthesis from the provitamin seems to be an important source for retinoids during development. However, the asymmetric cleavage reaction may contribute to RA formation in certain tissues during later stages of development. In this context, the observed expression of the beta -diox-II in brain and lung could be of relevance. In cell differentiation processes in the nervous system, RA plays an important role (29). In a ferret model, under certain conditions such as exposure to cigarette smoke, beta -carotene toxicity on lung has been reported (22). Asymmetric cleavage of beta -carotene was discussed as being involved in these toxic effects (for review see Ref. 30). Furthermore, RA formation from beta -carotene has been found in vitro in the testis, small intestine, liver, and kidney (18). Here, we show that in all these tissues mRNAs encoding the two different types of carotene dioxygenases are found. This indicates that besides the small intestine and liver, several tissues may contribute to their own RA homeostasis by endogenous retinoid formation from beta -carotene, until now an underestimated, unappreciated feature in retinoid homeostasis.

As judged in an E. coli test system, the enzyme was also able to catalyze the oxidative cleavage of lycopene. This indicates with respect to substrate specificity that the polyene chain backbone of carotenes plays an important role, whereas the ionone ring structures of beta -carotene seem to be of marginal relevance. This result was also obtained upon analyzing the mouse beta -diox (12). Favorable effects of lycopene on human health have been reported (31). Lycopene is accumulated primarily in liver but also in intestine, prostate, and testis, tissues in which both beta -diox and beta -diox-II mRNAs are expressed. The cleavage of lycopene and the formation of apolycopenals are indicative of a putative role in vertebrate physiology. In vertebrates, several nuclear receptors with unknown ligands exist, i.e. orphan receptors. Besides being a putative precursor for RA formation in the case of beta -carotene cleavage, the compounds formed by the asymmetric cleavage reaction of beta -carotene and/or lycopene may represent putative ligands for these receptors.

Taken together, the data presented here led to the molecular identification of an enzyme, beta ,beta -carotene-9',10'-dioxgenase, catalyzing the asymmetric cleavage of beta -carotene. Thus, besides the symmetric cleavage of beta -carotene, a second enzymatic activity is present in vertebrates. The molecular identification of enzymes involved in the cleavage of beta -carotene will open new avenues of research on the impact of metabolites derived from carotenes in animal physiology and human health.


    ACKNOWLEDGEMENTS

We thank Beate Ziser for skillful technical assistance and Randy Cassada for helpful discussion and for correcting the English version of the manuscript.


    FOOTNOTES

* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AJ290392, AJ290393, AJ290390, and AJ290391.

§ Both authors contributed equally to this work.

|| To whom correspondence should be addressed: Inst. of Biology I, Animal Physiology and Neurobiology, University of Freiburg, Hauptstrasse 1, D-79104 Freiburg, Germany. Tel.: 49 761 203 2539; Fax: 49 761 203 2921; E-mail: lintig@uni-freiburg.de.

Published, JBC Papers in Press, January 29, 2001, DOI 10.1074/jbc.M011510200

2 J. M. Lampert and J. v. Lintig, unpublished results.


    ABBREVIATIONS

The abbreviations used are: RA, retinoic acid; beta -diox, beta ,beta -carotene-15,15'-dioxygenase; EST, expressed sequence tag; RACE, rapid amplification of cDNA ends; PCR, polymerase chain reaction; RT-PCR, reverse transcription-PCR; beta -diox-II, beta ,beta -carotene-9',10'-dioxygenase; Tricine, N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine; HPLC, high performance liquid chromatography; LC, liquid chromatography; MS, mass spectrometry; GC, gas chromatography; APcI, atmospheric pressure chemical ionization; RPE, retinal pigment epithelium.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES


1. Wald, G. (1968) Nature 219, 800-807[Medline] [Order article via Infotrieve]
2. Vogt, K. (1984) Z. Naturforsch. 39, 196-197
3. Dowling, J. E., and Wald, G. (1960) Proc. Natl. Acad. Sci. U. S. A. 46, 587-608
4. Giguere, V., Ong, E. S., Segui, P., and Evans, R. M. (1987) Nature 330, 624-629[CrossRef][Medline] [Order article via Infotrieve]
5. Chambon, P. (1996) FASEB. J. 10, 940-954[Abstract/Free Full Text]
6. Goodman, D. S., and Huang, H. S. (1965) Science 149, 879-880
7. Glover, J. (1960) Vitam. Horm. 18, 371-386
8. Wolf, G. (1995) Nutr. Rev. 53, 134-137[Medline] [Order article via Infotrieve]
9. Schwartz, S. H., Tan, B. C., Gage, D. A., Zeevaart, J. A. D., and McCarty, D. R. (1997) Science 276, 1872-1874[Abstract/Free Full Text]
10. von Lintig, J., and Vogt, K. (2000) J. Biol. Chem. 275, 11915-11920[Abstract/Free Full Text]
11. Wyss, A., Wirtz, G., Woggon, W., Brugger, R., Wyss, M., Friedlein, A., Bachmann, H., and Hunziker, W. (2000) Biochem. Biophys. Res. Commun. 271, 334-336[CrossRef][Medline] [Order article via Infotrieve]
12. Redmond, T. M., Gentleman, S., Duncan, T., Yu, S., Wiggert, B., Gantt, E., and Cunningham, F. X., Jr. (2001) J. Biol. Chem. 276, 6560-6565[Abstract/Free Full Text]
13. Tan, B. C., Schwartz, S. H., Zeevaart, J. A. D., and McCarty, D. R. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 12235-12240[Abstract/Free Full Text]
14. Bavik, C. O., Eriksson, U., Allen, R. A., and Peterson, P. A. (1991) J. Biol. Chem. 266, 14978-14985[Abstract/Free Full Text]
15. Hamel, C. P., Tsilou, E., Pfeffer, B. A., Hooks, J. J., Detrick, B., and Redmond, T. M. (1993) J. Biol. Chem. 268, 15751-15757[Abstract/Free Full Text]
16. Redmond, T. M., Yu, S., Lee, E., Bok, D., Hamasaki, D., Chen, N., Goletz, P., Ma, J. X., Crouch, R. K., and Pfeifer, K. (1998) Nat. Genet. 20, 344-351[CrossRef][Medline] [Order article via Infotrieve]
17. von Lintig, J., Dreher, A., Kiefer, C., Wernet, M. F., and Vogt, K. (2001) Proc. Natl. Acad. Sci. U. S. A. 98, 1130-1135[Abstract/Free Full Text]
18. Napoli, J. L., and Race, K. R. (1988) J. Biol. Chem. 263, 17372-17377[Abstract/Free Full Text]
19. Wang, X. D., Tang, G. W., Fox, J. G., Krinsky, N. I., and Russell, R. M. (1991) Arch. Biochem. Biophys. 285, 8-16[Medline] [Order article via Infotrieve]
20. Tang, G. W., Wang, X. D., Russell, R. M., and Krinsky, N. I. (1991) Biochemistry 30, 9829-9834[Medline] [Order article via Infotrieve]
21. Wang, X. D., Russell, R. M., Liu, C., Stickel, F., Smith, D. E., and Krinsky, N. I. (1996) J. Biol. Chem. 271, 26490-26498[Abstract/Free Full Text]
22. Wang, X. D., Liu, C., Bronson, R. T., Smith, D. E., Krinsky, N. I., and Russel, R. M. (1999) J. Natl. Cancer Inst. 91, 60-66[Abstract/Free Full Text]
23. von Lintig, J., Welsch, R., Bonk, M., Giuliano, G., Batschauer, A., and Kleinig, H. (1997) Plant J. 12, 625-634[CrossRef][Medline] [Order article via Infotrieve]
24. Nagao, A., During, A., Hoshino, C., Terao, J., and Olson, J. A. (1996) Arch. Biochem. Biophys. 328, 57-63[CrossRef][Medline] [Order article via Infotrieve]
25. Barua, A. B., and Olson, J. A. (2000) J. Nutr. 130, 1996-2001[Abstract/Free Full Text]
26. Saitou, N., and Nei, M. (1987) Mol. Biol. Evol. 4, 406-425[Abstract]
27. Henry, L. K., Puspitasari-Nienaber, N. L., Jaren-Galan, M., van Breemen, R. B., Catignani, G. L., and Schwartz, S. J. (2000) J. Agric. Food Chem. 48, 5008-5013[CrossRef][Medline] [Order article via Infotrieve]
28. Sharma, R. V., Mathur, S. N., and Ganguly, J. (1976) Biochem. J. 158, 377-383[Medline] [Order article via Infotrieve]
29. McCaffery, P., and Drager, U. C. (2000) Cytokine Growth Factor Rev. 11, 233-249[CrossRef][Medline] [Order article via Infotrieve]
30. Russell, R. M. (2000) Am. J. Clin. Nutr. 71, 878-884[Abstract/Free Full Text]
31. Clinton, S. K. (1998) Nutr. Rev. 56, 35-51[Medline] [Order article via Infotrieve]


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.